Search

Your search keyword '"Fortini, Monica"' showing total 4 results
Start Over Author "Fortini, Monica" Topic sars-cov-2
4 results on '"Fortini, Monica"'

1. Thalassaemia is paradoxically associated with a reduced risk of in‐hospital complications and mortality in COVID‐19: Data from an international registry.

Author

El‐Battrawy, Ibrahim, Longo, Filomena, Núñez Gil, Iván J., Abumayyaleh, Mohammad, Gianesin, Barbara, Estrada, Vicente, Aparisi, Álvaro, Arroyo‐Espliguero, Ramón, Balocco, Manuela, Barella, Susanna, Beccaria, Andrea, Bonetti, Federico, Casale, Maddalena, De michele, Elisa, Denotti, Anna Rita, Fidone, Carmelo, Fortini, Monica, Gamberini, Maria Rita, Graziadei, Giovanna, and Lisi, Roberto

Subjects
THALASSEMIA, HOSPITAL mortality, CONTINUOUS positive airway pressure, COVID-19, ACUTE kidney failure
Abstract

Although numerous patient‐specific co‐factors have been shown to be associated with worse outcomes in COVID‐19, the prognostic value of thalassaemic syndromes in COVID‐19 patients remains poorly understood. We studied the outcomes of 137 COVID‐19 patients with a history of transfusion‐dependent thalassaemia (TDT) and transfusion independent thalassaemia (TIT) extracted from a large international cohort and compared them with the outcomes from a matched cohort of COVID‐19 patients with no history of thalassaemia. The mean age of thalassaemia patients included in our study was 41 ± 16 years (48.9% male). Almost 81% of these patients suffered from TDT requiring blood transfusions on a regular basis. 38.7% of patients were blood group O. Cardiac iron overload was documented in 6.8% of study patients, whereas liver iron overload was documented in 35% of study patients. 40% of thalassaemia patients had a history of splenectomy. 27.7% of study patients required hospitalization due to COVID‐19 infection. Amongst the hospitalized patients, one patient died (0.7%) and one patient required intubation. Continuous positive airway pressure (CPAP) was required in almost 5% of study patients. After adjustment for age‐, sex‐ and other known risk factors (cardiac disease, kidney disease and pulmonary disease), the rate of in‐hospital complications (supplemental oxygen use, admission to an intensive care unit for CPAP therapy or intubation) and all‐cause mortality was significantly lower in the thalassaemia group compared to the matched cohort with no history of thalassaemia. Amongst thalassaemia patients in general, the TIT group exhibited a higher rate of hospitalization compared to the TDT group (p = 0.001). In addition, the rate of complications such as acute kidney injury and need for supplemental oxygen was significantly higher in the TIT group compared to the TDT group. In the multivariable logistic regression analysis, age and history of heart or kidney disease were all found to be independent risk factors for increased in‐hospital, all‐cause mortality, whereas the presence of thalassaemia (either TDT or TIT) was found to be independently associated with reduced all‐cause mortality. The presence of thalassaemia in COVID‐19 patients was independently associated with lower in‐hospital, all‐cause mortality and few in‐hospital complications in our study. The pathophysiology of this is unclear and needs to be studied in vitro and in animal models. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

2. Premature aging of the immune system affects the response to SARS-CoV-2 mRNA vaccine in β-thalassemia: role of an additional dose

Author

Rita Carsetti, Chiara Agrati, Valeria Maria Pinto, Barbara Gianesin, Rita Gamberini, Monica Fortini, Susanna Barella, Rita Denotti, Silverio Perrotta, Maddalena Casale, Aurelio Maggio, Lorella Pitrolo, Eleonora Tartaglia, Eva Piano Mortari, Francesca Colavita, Vincenzo Puro, Massimo Francalancia, Valeria Marini, Marco Caminati, Filippo Mazzi, Lucia De Franceschi, Gian Luca Forni, Franco Locatelli, Carsetti, Rita, Agrati, Chiara, Pinto, Valeria Maria, Gianesin, Barbara, Gamberini, Rita, Fortini, Monica, Barella, Susanna, Denotti, Rita, Perrotta, Silverio, Casale, Maddalena, Maggio, Aurelio, Pitrolo, Lorella, Tartaglia, Eleonora, Mortari, Eva Piano, Colavita, Francesca, Puro, Vincenzo, Francalancia, Massimo, Marini, Valeria, Caminati, Marco, Mazzi, Filippo, De Franceschi, Lucia, Forni, Gian Luca, and Locatelli, Franco

Subjects
thalassemia, Vaccines, Synthetic, COVID-19 Vaccines, SARS-CoV-2, beta-Thalassemia, Immunology, COVID-19, Aging, Premature, Cell Biology, Hematology, Antibodies, Viral, Biochemistry, Settore MED/38 - PEDIATRIA GENERALE E SPECIALISTICA, Immune System, Humans, mRNA Vaccines
Abstract

Patients with beta-thalassemia show 5-fold increase in agestandardized lethality due to SARS-CoV-2 infection, representing a high-risk population compared with age- and sex-matched healthy subjects.(1) Vaccination against SARS-CoV-2 is crucial to reduce mortality and morbidity of frail patients.(2) Up to now, limited data have been available on the responses of patients with beta-thalassemia immunized with anti-SARS-CoV-2 mRNA vaccines.(3)

Published
2022

3. Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection

Author

Sabrina Quintino, Filomena Longo, Maurizio Miano, Vincenzo Voi, Maria Caterina Putti, Margerita Migone De Amicis, Monica Fortini, Susanna Barella, Barbara Gianesin, Federico Bonetti, Andrea Beccaria, Manuela Balocco, Andrea Piolatto, Saveria Campisi, Rosamaria Rosso, Angelantonio Vitucci, Valentina Carrai, Alessandra Quota, Zelia Borsellino, Antonio Piga, Maddalena Casale, Anna Rita Denotti, Michela Ribersani, Maria Rita Gamberini, Domenico Roberti, Alberto Piperno, Roberto Lisi, Carmelo Fidone, Maria Domenica Cappellini, Sabrina Bagnato, Anna De Giovanni, Micol Quaresima, Valeria Maria, Lorella Pitrolo, Marco Marziali, Giovanna Graziadei, Carmen Gaglioti, Aldo Filosa, Chiara Dal Zotto, Lucia De Franceschi, Irene Motta, Immacolata Tartaglione, Francesco Arcioni, Aurelio Maggio, Marilena Serra, Giovan Battista Ruffo, Massimo Gentile, Elisa De Michele, Anna Spasiano, Paolo Ricchi, Antonella Massa, Silverio Perrotta, R. Mariani, Gian Luca Forni, Longo, Filomena, Gianesin, Barbara, Voi, Vincenzo, Motta, Irene, Pinto, Valeria Maria, Piolatto, Andrea, Spasiano, Anna, Ruffo, Giovan Battista, Gamberini, Maria Rita, Barella, Susanna, Mariani, Raffaella, Fidone, Carmelo, Rosso, Rosamaria, Casale, Maddalena, Roberti, Domenico, Dal Zotto, Chiara, Vitucci, Angelantonio, Bonetti, Federico, Pitrolo, Lorella, Quaresima, Micol, Ribersani, Michela, Quota, Alessandra, Arcioni, Francesco, Campisi, Saveria, Massa, Antonella, De Michele, Elisa, Lisi, Roberto, Miano, Maurizio, Bagnato, Sabrina, Gentile, Massimo, Carrai, Valentina, Putti, Maria Caterina, Serra, Marilena, Gaglioti, Carmen, Migone De Amicis, Margerita, Graziadei, Giovanna, De Giovanni, Anna, Ricchi, Paolo, Balocco, Manuela, Quintino, Sabrina, Borsellino, Zelia, Fortini, Monica, Denotti, Anna Rita, Tartaglione, Immacolata, Beccaria, Andrea, Marziali, Marco, Maggio, Aurelio, Perrotta, Silverio, Piperno, Alberto, Filosa, Aldo, Cappellini, Maria Domenica, De Franceschi, Lucia, Piga, Antonio, and Forni, Gian Luca

Subjects
Sars-CoV-2, business.industry, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Sars-CoV-2, hemoglobinopathies, Medicine, hemoglobinopathies,SARS-CoV-2 infection, Lethality, Hematology, hemoglobinopathies, business, Virology
Published
2022

4. Thalassemia Is Paradoxically Associated with a Reduced Risk of In-Hospital Complications and Mortality in COVID-19: Data from an International Registry

Author

Ibrahim El-Battrawy, Elisa De Michele, Manuela Balocco, Immacolata Tartaglione, Carmelo Fidone, Roberto Lisi, Maria Caterina Putti, Marcos Garca-Aguado, Michela Ribersani, Ramón Arroyo-Espliguero, Vicente Estrada, Lucia De Franceschi, Maurizio Miano, Antonella Massa, Alessandra Quota, Vincenzo Voi, Monica Fortini, Maria Domenica Cappellini, Inmaculada Fernández-Rozas, Marco Marziali, Giovanna Graziadei, Angelantonio Vitucci, Alberto Piperno, Iván Núñez Gil Md, Irene Motta, Wulandewi Marhaeni, Marco Zecca, Maddalena Casale, Antonio Piga, Silverio Perrotta, Bryan Rupinski, Charbel Maroun, Filomena Longo, Rodolfo Romero, R. Mariani, Domenico Roberti, Susanna Barella, Andrea Beccaria, Valeria Pinto, Barbara Gianesin, Mohammad Abumayyaleh, Rosamaria Rosso, Carolina Espejo Paeres, Álvaro Aparisi, Gian Luca Forni, Rita Gamberini, Ibrahim Akin, Anna Rita Denotti, Federico Bonetti, Alessia Marcon, El-Battrawy, Ibrahim, Longo, Filomena, Núñez Gil, Iván J, Abumayyaleh, Mohammad, Gianesin, Barbara, Estrada, Vicente, Aparisi, Álvaro, Arroyo-Espliguero, Ramón, Balocco, Manuela, Barella, Susanna, Beccaria, Andrea, Bonetti, Federico, Casale, Maddalena, De Michele, Elisa, Denotti, Anna Rita, Fidone, Carmelo, Fortini, Monica, Gamberini, Maria Rita, Graziadei, Giovanna, Lisi, Roberto, Massa, Antonella, Marcon, Alessia, Rubinski, Bryan, Miano, Maurizio, Motta, Irene, Pinto, Valeria Maria, Piperno, Alberto, Mariani, Raffaella, Putti, Maria Caterina, Quota, Alessandra, Ribersani, Michela, Marziali, Marco, Roberti, Domenico, Rosso, Rosamaria, Tartaglione, Immacolata, Vitucci, Angelantonio, Voi, Vincenzo, Zecca, Marco, Romero, Rodolfo, Marouneld, Charbel, Fernández-Rozas, Inmaculada, Espejo, Carolina, Marhaeni, Wulandewi, Garcia Aguado, Marco, Cappellini, Maria Domenica, Perrotta, Silverio, De Franceschi, Lucia, Piga, Antonio, Forni, Gian Luca, and Akin, Ibrahim

Subjects
Male, Pediatrics, medicine.medical_specialty, Iron Overload, Thalassemia, medicine.medical_treatment, Splenectomy, thalassaemia, Disease, law.invention, law, medicine, Humans, Registries, Continuous positive airway pressure, COVID-19, SARS-CoV-2, mortality, business.industry, Acute kidney injury, Cell Biology, medicine.disease, Intensive care unit, Hospitals, Oxygen, Cohort, Molecular Medicine, Female, business, Kidney disease
Abstract

Background: Although numerous patient specific co-factors have been shown to be associated with worse outcomes in COVID-19, the prognostic value of thalasemic syndromes in COVID-19 patients remains poorly understood. Aims: We studied the outcomes of 137 COVID-19 patients with a history of Transfusion Dependent Thalassemia (TDT) and non-Transfusion Dependent Thalassemia (NTDT) extracted from a large international cohort and compared them with the outcomes from a matched cohort of COVID-19 patients with no history of thalasemia. Results: The mean age of thalassemia patients included in our study was 41±16 years (48.9% male). Almost 81% of these patients suffered from TDT requiring blood transfusions on a regular basis. 38.7% of patients were blood group O. Cardiac iron overload was documented in 6.8% of study patients, whereas liver iron overload was documented in 35% of study patients. 25% of thalassemia patients had a history of splenectomy. 27.7% of study patients required hospitalization due to COVID-19 infection. Amongst the hospitalized patients, one patient died (0.7%) and one patient required intubation. Continuous positive airway pressure (CPAP) was required in almost 5% of study patients. After adjustment for age-, sex- and other known risk factors (cardiac disease, kidney disease and pulmonary disease), the rate of in-hospital complications (supplemental oxygen use, admission to the an intensive care unit for CPAP therapy or intubation) and all-cause mortality was significantly lower in the thalassemia group compared to the matched cohort with no history of thalassemia. Amongst thalassemia patients in general, the NTDT group exhibited a higher rate of hospitalization compared to the TDT group (p=0.001). In addition, the rate of complications such as acute kidney injury and need for supplemental oxygen was significantly higher in the NTDT group compared to the TDT group. In the multivariable logistic regression analysis, age and history of heart or kidney disease were all found to be independent risk factors for increased in-hospital, all-cause mortality, whereas the presence of thalassemia (either TDT or NTDT) was found to be independently associated with reduced all-cause mortality. Conclusions: The presence of thalassemia in COVID-19 patients was independently associated with lower in-hospital, all-cause mortality and few in-hospital complications in in our study. The pathophysiology of this is unclear and needs to be studied in vitro and in animal models. Trial Registration for sources of data extraction: NCT: 04334291, 04746066 Funding Statement: This study was funded by a non-conditioned grant from FUNDACION INTERHOSPITALARIA PARA LA INVESTIGACION CARDIOVASCULAR, FIC. (Madrid, Spain). This nonprofit institution had no role in the study design, the collection, analysis and interpretation of data, the writing of the report, or the decision to submit the paper for publication. Declaration of Interests: The authors declare no conflicts of interest. Ethics Approval Statement: The study was approved by the Ethics Committees in all of the centers involved (Banjarmasin, Bari, Cagliari, Catania, Ferrara, Gela, Genoa, Getafe, Guadalajara, Legan, Madrid, Mannheim, Milan, Monza, Naples, Olbia, Padua, Pavia, Ragusa, Rome, Salerno, Turin, Valladolid and Verona).

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results